0001181431-15-006892.txt : 20150513 0001181431-15-006892.hdr.sgml : 20150513 20150513203729 ACCESSION NUMBER: 0001181431-15-006892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150511 FILED AS OF DATE: 20150513 DATE AS OF CHANGE: 20150513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 3105362506 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE INC DATE OF NAME CHANGE: 19940719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JIGANTI JEANINE MARIE CENTRAL INDEX KEY: 0001566865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 15859985 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 4 1 rrd424942.xml FORM 4 X0306 4 2015-05-11 0 0000927066 DAVITA HEALTHCARE PARTNERS INC. DVA 0001566865 JIGANTI JEANINE MARIE C/O DAVITA HEALTHCARE PARTNERS INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Compliance Officer Common Stock 2015-05-11 4 M 0 4687 48.6800 A 8213 D Common Stock 2015-05-11 4 F 0 2777 82.1700 D 5436 D Common Stock 2015-05-11 4 S 0 1910 81.9692 D 3526 D Common Stock 2015-05-11 4 S 0 571 81.8768 D 2955 D Stock Appreciation Rights 48.6800 2015-05-11 4 M 0 4687 0 D 2013-07-09 2017-07-09 Common Stock 4687 4688 D Represents the weighted average sale price of $81.9692. The range of prices for the sale of these shares was $81.945 - $81.995, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average sale price of $81.8768. The range of prices for the sale of these shares was $81.871 - $81.882, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted to the Reporting Person on 7/9/2012, pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, as amended and restated; 25% vested on 7/9/2013 (one-year fron the grant date), and the remaining 75% vests quarterly over the remaining three years from the grant date. /s/ Arturo Sida, Attorney-in-Fact 2015-05-12